Barclays’s Proterra Inc. Common Stock PTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-44,060
Closed -$52.9K 4787
2023
Q2
$52.9K Sell
44,060
-69,103
-61% -$84.9K ﹤0.01% 3816
2023
Q1
$172K Buy
113,163
+53,125
+88% +$200K ﹤0.01% 3879
2022
Q4
$226K Buy
60,038
+50,663
+540% +$268K ﹤0.01% 3773
2022
Q3
$47K Sell
9,375
-1,746
-16% -$9.79K ﹤0.01% 3798
2022
Q2
$51K Buy
11,121
+680
+7% +$4.16K ﹤0.01% 4026
2022
Q1
$79K Buy
+10,441
New +$84.6K ﹤0.01% 3902

Other funds holding PTRA

Barclays's PTRA Position: Q3 2023 in Review

Barclays sold out of Proterra Inc. Common Stock (PTRA) in Q3 2023, closing a stake of 44,060 shares — an estimated $52.9K sold.

Barclays first reported a position in PTRA in Q1 2022 and held it in 6 quarters. The position peaked at $226K in Q4 2022. 7 funds tracked by Wall St. Rank hold PTRA as of Q3 2023.

  • Barclays reported no remaining Proterra Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Barclays sold 44,060 Proterra Inc. Common Stock shares in Q3 2023, an estimated $52.9K.
  • Barclays first reported a position in Proterra Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Barclays's Proterra Inc. Common Stock position peaked at $226K in Q4 2022.
  • 7 funds tracked by Wall St. Rank held Proterra Inc. Common Stock as of Q3 2023.

Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.